 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Avidity Biosciences to Participate in Upcoming Investor Conferences Avidity Biosciences to Participate in Upcoming Investor Conferences PR Newswire SAN DIEGO, Sept. 25, 2023 SAN DIEGO, Sept. 25, 2023...

Avidity Biosciences to Participate in Upcoming Investor Conferences

This indicator may be signaling that RNA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Avidity Biosciences (RNA, $6.45) entered Downtrend as Momentum indicator drops below 0 level on Sep 22, 2023

This indicator may be signaling RNA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Avidity Biosciences (RNA, $7.06) entered Uptrend as Momentum indicator ascends above 0 level on Sep 20, 2023

For the last three days, A.I.dvisor has detected that RNA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Avidity Biosciences (RNA, $7.06) Aroon Indicator entered a Downtrend on September 20, 2023.

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Sept...

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Avidity Biosciences (RNA, $6.96) Aroon Indicator entered a Downtrend on September 18, 2023.

Avidity Biosciences (RNA, $7.01) Aroon Indicator entered a Downtrend on September 15, 2023.

Avidity Biosciences (RNA, $7.29) Aroon Indicator entered a Downtrend on September 14, 2023.

Avidity Biosciences (RNA, $7.11) Aroon Indicator entered a Downtrend on September 13, 2023.

Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023 Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023 PR Newswire VANCOUVER, BC, Sept...

Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Watchers	892
52-Wk Low	$6.36
52-Wk High	$25.74

Market Cap	$477.92M
Volume (M)	1.64M
52-Wk High	$25.74
52-Wk Low	$6.36

RNA Avidity Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals